October 29Oct 29 Up until now, several studies have shown that patients taking the medication (which is commonly referred to by brand names such as Mounjaro or Wegovy) have reported a reduced alcohol consumption overall, but a new study has now shown that even patients still drinking alcohol are metabolizing it differently.As part of the study, 20 adults with obesity—half of whom had been taking GLP-1 receptor agonists for at least four weeks—were investigated to see how they responded to alcohol.Both groups fasted overnight, then tucked into an identical snack before drinking alcoholic beverages that had been specifically designed to reach about 0.08 on a breathalyzer.Participants taking GLP-1s showed a slower rise in breath alcohol during the first 10 to 20 minutes and lower overall levels throughout. They also reported feeling far less drunk early on, hinting at a delayed response to alcohol metabolism.Read more about the study here.
Create an account or sign in to comment